Skip to content

AccelStim UBHS-02Recalls & reported problems

Igea SPA · Bone Growth Stimulator · Class 2

Adverse event reports
4
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08050040997213), received between Jun 5, 2023 and Jul 22, 2025 — classified as 4 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Insufficient Device Problem Information1

Patient problems

  • Burn(s)3
  • High Blood Pressure/ Hypertension1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 22, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    THE PATIENT CLAIMED THE DEVICE RAISED HER BLOOD PRESSURE CAUSED HER TO GO TO THE EMERGENCY ROOM. ON (B)(6) 2025, A CALL WAS MADE TO THE PATIENT TO GAIN ADDITIONAL INFORMATION. PATIENT DECLINED TO PROVIDE ADDITIONAL DETAILS REGARDING HER EXPERIENCE.

    Patient problems: High Blood Pressure/ Hypertension

    MAUDE report 22569918 ↗
  • InjuryMar 24, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PATIENT CALLED AND REPORTED THAT SHE TRIED A DIFFERENT TYPE OF GEL, WHICH SHE USED A MINERAL OIL/BABY OIL AND THE UNIT HAS BURNED HER FOR THE SECOND TIME. PATIENT WAS UNABLE TO PROVIDE PICTURES AND STATED THAT THE BURN HAS HEALED.

    Patient problems: Burn(s)

    MAUDE report 21678918 ↗
  • InjuryJun 5, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    INFORMATION PROVIDED STATES THAT PATIENT WAS PRESCRIBED ACCELSTIM DEVICE (B)(6) 2022. PT SAID SHE USED DEVICE FOR 5 MONTHS WITH NO ISSUES. SHE STATED THAT SHE HAS GOTTEN BURNED TWICE, ONCE 5 WEEKS PRIOR TO CALLING CUSTOMER SERVICE AND AGAIN 3 WEEKS LATER. PT DISCONTINUED USE OF THE DEVICE. THE DEVICE WAS REPLACED WITH A NEW UNIT.

    Patient problems: Burn(s)

    MAUDE report 17066044 ↗
  • InjuryJun 5, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    INFORMATION PROVIDED STATES THAT PATIENT WAS PRESCRIBED ACCELSTIM DEVICE (B)(6) 2022. PT SAID SHE ONLY USED IT 3-4 TIMES. AFTER LAST TREATMENT RED BURNS APPEARED ABOUT THE SIZE OF THE DEVICE ON HER FOOT, 2-3 BURNS ON THE BACK BOTTOM OF HER FOOT WHERE THE DEVICE WAS AND ON THE TOP OF THE FOOT. SHE STOPPED USING THE DEVICE. PATIENT SAID THE BURNS HAVE SINCE HEALED . PT STATED SHE TRIED ALTERNATIVE MINERAL OIL AND GLYCERIN WITH THE SAME RESULTS.

    Patient problems: Burn(s)

    MAUDE report 17059858 ↗

Other Stimulator, Bone Growth, Non-Invasive devices

All Stimulator, Bone Growth, Non-Invasive devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.